Feeding behavior in dopamine-deficient mice.

Mice that cannot make dopamine (DA), a condition caused by the selective inactivation of tyrosine hydroxylase in dopaminergic neurons, are born normal but gradually become hypoactive and hypophagic, and die at 3 weeks of age. We characterized the feeding and locomotor responses of these DA-deficient (DA-/-) mice to 3, 4-dihyroxy-L-phenylalanine (L-DOPA) to investigate the relationship between brain DA levels and these complex behaviors. Daily administration of L-DOPA to DA-/- mice stimulated locomotor activity that lasted 6 to 9 hr; during that time the mice consumed most of their daily food and water. The minimal dose of L-DOPA that was sufficient to elicit normal feeding behavior in the DA-/- mice also restored their striatal DA to 9.1% of that in the wild-type (WT) mice at 3 hr; then DA content declined to <1% of WT levels by 24 hr. This dose of L-DOPA induced locomotor activity that exceeded that of treated WT mice by 5- to 7-fold, suggesting that DA-/- mice are supersensitive to DA. Unexpectedly, DA-/- mice manifested a second wave of activity 24 to 48 hr after L-DOPA treatment that was equivalent in magnitude to that of WT mice and independent of DA receptor activation. The DA-/- mice approached, sniffed, and chewed food during this second period of activity, but they ate <10% of that required for sustenance. Therefore, DA-/- mice can execute behaviors necessary to seek and ingest food, but they do not eat enough to survive.

[1]  P. Emson,et al.  Co-expression of cholecystokinin mRNA and tyrosine hydroxylase mRNA in populations of rat substantia nigra cells; a study using a combined radioactive and non-radioactive in situ hybridization procedure. , 1991, Brain research. Molecular brain research.

[2]  H. Fibiger,et al.  Attenuation of amphetamine‐induced motor stimulation and stereotypy by 6‐hydroxydopamine in the rat , 1973, British journal of pharmacology.

[3]  S. Dunnett,et al.  Nigral grafts in neonatal rats: protection from aphagia induced by subsequent adult 6-OHDA lesions. , 1990, Progress in brain research.

[4]  S. Haber,et al.  Dopamine Neurons Make Glutamatergic Synapses In Vitro , 1998, The Journal of Neuroscience.

[5]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. , 1991, European journal of pharmacology.

[6]  R. Palmiter,et al.  Restoration of Norepinephrine and Reversal of Phenotypes in Mice Lacking Dopamine β‐Hydroxylase , 1998, Journal of neurochemistry.

[7]  E. Stricker,et al.  Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions. , 1976, Journal of comparative and physiological psychology.

[8]  R. Palmiter,et al.  Viral Gene Delivery Selectively Restores Feeding and Prevents Lethality of Dopamine-Deficient Mice , 1999, Neuron.

[9]  E. Stricker,et al.  Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats , 1972, Science.

[10]  A. Kelley,et al.  Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  P. Teitelbaum,et al.  Further analysis of sensory inattention following lateral hypothalamic damage in rats. , 1974, Journal of comparative and physiological psychology.

[12]  M. Zigmond,et al.  The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. , 1980, Progress in neuro-psychopharmacology.

[13]  M. Molliver,et al.  6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat. , 1987, Brain research.

[14]  M. Zigmond,et al.  Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. , 1977, The Journal of pharmacology and experimental therapeutics.

[15]  A. M. Snyder,et al.  Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats , 1984, Brain Research.

[16]  S. Markey,et al.  MPTP Toxicity: Implications for Research in Parkinson's Disease , 1988 .

[17]  S. Augood,et al.  Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study , 1996, Neuroscience.

[18]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[19]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[20]  Ming Xu,et al.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses , 1994, Cell.

[21]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[23]  T. Ljungberg,et al.  Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs. , 1977, Advances in biochemical psychopharmacology.

[24]  P. Emson,et al.  Colchicine-induced expression of proneurotensin mRNA in rat striatum and hypothalamus. , 1991, Brain research. Molecular brain research.

[25]  J. Salamone,et al.  Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. , 1989, Archives of neurology.

[26]  U. Ungerstedt,et al.  Apomorphine-induced restoration of drinking to thirst challenges in 6-hydroxydopamine-treated rats , 1976, Physiology & Behavior.

[27]  M. Zigmond,et al.  Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. , 1989, International review of neurobiology.

[28]  T. Ljungberg,et al.  Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats , 1976, Physiology & Behavior.

[29]  P. Teitelbaum,et al.  A comparison of the eating in response to hypothermic and glucoprivic challenges after nigral 6-hydroxydopamine and lateral hypothalamic electrolytic lesions in rats. , 1973, Brain research.

[30]  B. Cooper,et al.  Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine. , 1973, The Journal of pharmacology and experimental therapeutics.

[31]  U. Ungerstedt Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[32]  K. Fuxe,et al.  Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.

[33]  R. Palmiter,et al.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic , 1995, Cell.

[34]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[35]  N. Ogawa,et al.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion , 1997, Journal of Neuroscience Methods.